期刊信息/Journal information
：中国抗癌协会
：郝希山
：季刊
：2095-3941
：12-1431/R
：editor@cancerbiomed.org
：022-23522919
：300060
：天津市河西区体院北环湖西路天津市肿瘤医院C座综合楼三楼
癌症生物学与医学（英文版）/Journal Cancer Biology & MedicineCSCDCSTPCDMEDLINESCI
Cancer Biology & Medicine is a peer-reviewed open-access journal of Chinese Anti-cancer Association ...展开全部>>
收录年代
Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectives
Jing Yu;Maochen Li;Yuhan Zhu;Shengnan Wang;Yuzhao Jiang;Wei Cui;Lingying Wu788-795
Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer
Mingyue Zhao;Rui Chen;Ping Gao810-832
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A
Hongjuan You;Delong Kong;Xiucheng Pan;Xiaocui Li;Suping Qin;Kuiyang Zheng;Chen Li;Renxian Tang;Fanyun Kong;Xing Wang;Ruyu Liu;Yuxin Wang;Huanyang Zhang;Lihong Ma;Ensi Bao;Yujie Zhong;Xiangye Liu888-909
Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
Di Shao;Tianjian Yu;Yi Xiao;Zhiming Shao925-945
From overtreatment to precision:a new clinical standard for DCIS management
Schlomo Schneebaum785-787
Chinese expert consensus on additional surgery following endoscopic resection for early colorectal cancer(2025 edition)
Zhipeng Qi;Society of Surgery;Society of Digestive Endoscopy;Colorectal Tumor Committee;Fuqiang Zhao;Xuhua Hu;Yunshi Zhong;Qian Liu;Zhongtao Zhang;Guiying Wang796-809
Drug resistance to antibody-drug conjugates:mechanisms,challenges,and perspectives
Yajing Liu;Yuwei Liu;Tingting Wu;Xiaoming Bai;Shuman Wang;Luyun Zhang;Zhiwen Fu;Chen Shi833-864
Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage Ⅲ non-small cell lung cancer
Yuzhen Cui;Jingdong Xu;Junxu Wen;Jianfeng Peng;Jiangao Ren;Ailing Liu;Xiangjiao Meng;Zhaoqin Huang;Anwen Liu865-887
Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process:a preclinical study for solid tumors
Ying Zhang;Wenjia Zhuang;Huajun Jin;Jianming Xu;Sicheng Du;Rongrui Liu;Chuanhua Zhao;Juan Li;Sisi Ye;Man Zhang;Xingming Ma;Zhou He910-924
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma:a retrospective real-world analysis
Yang Liu;Yong Xu;Huikai Li;Chuntao Gao;Jihui Hao;Dandan Wu;Xing Li;Xihao Zhang;Rentao Li;Yanmei Ou;Hao Wang;Tongguo Si;Rui Xia946-950